Fresenius Medical Care AG & Co. KGaA (FMS) reported full-year 2012 net income attributable to shareholders of $1.19 billion, up 11 percent from full year 2011. Excluding a positive non-taxable investment gain in the amount of $140 million and one-time costs in the amount of $71 million, net income attributable to shareholders was $1.12 billion, an increase of 4 percent from prior year. Net revenue for the full year 2012 was $13.81 billion, up 10 percent from prior year.
Operating income, or EBIT, increased by 7 percent. Excluding one-time costs the operating income increased by 12%.
For the full year 2013, Fresenius Medical Care expects revenue to grow to more than $14.6 billion. Net income attributable to shareholders is expected to be between $1.1 billion and $1.2 billion. The company said, based on the net income for 2012 excluding the investment gain, the expected earnings growth in 2013 is between 5 percent and 15 percent.
The company also proposed an increased annual dividend. At the Annual General Meeting, shareholders will be asked to approve a dividend per ordinary share of 0.75 euros, an increase of 9% from prior year.
For comments and feedback: editorial@rttnews.com